View in EDS HTML Full Text PDF Full Text

A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.

Saved in:
Bibliographic Details
Title: A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.
Authors: Becker NP; Berlin Cures GmbH, Dept. Regulatory Affairs, Knesebeck Str. 59-61, 10719, Berlin, Germany., Haberland A; Berlin Cures GmbH, Dept. Regulatory Affairs, Robert-Rössle-Str. 10, 13125, Berlin, Germany. haberland@berlincures.de., Wenzel K; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Göttel P; Berlin Cures GmbH, COO, Knesebeck Str. 59-61, 10719, Berlin, Germany., Wallukat G; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Davideit H; Berlin Cures GmbH, Dept. Quality Management, Robert-Rössle-Str. 10, 13125, Berlin, Germany.; Life Molecular Imaging GmbH, Berlin, Germany., Schulze-Rothe S; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Hönicke AS; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Schimke I; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Bartel S; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Grossmann M; Parexel International GmbH, Berlin, Germany., Sinn A; Parexel International GmbH, Berlin, Germany., Iavarone L; Parexel International GmbH, Berlin, Germany., Boergermann JH; Parexel International GmbH, Berlin, Germany., Prilliman K; Parexel International GmbH, Berlin, Germany.; Veristat, Southborough, MA, United States., Golor G; Parexel International GmbH, Berlin, Germany.; Biokinetica GmbH, Berlin, Germany., Müller J; Berlin Cures GmbH, CEO, Knesebeck Str. 59-61, 10719, Berlin, Germany., Becker S; Berlin Cures GmbH, Clinical Operations, Knesebeck Str. 59-61, 10719, Berlin, Germany.
Source: Clinical drug investigation [Clin Drug Investig] 2020 May; Vol. 40 (5), pp. 433-447.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32222912
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Becker+NP%22">Becker NP</searchLink>; Berlin Cures GmbH, Dept. Regulatory Affairs, Knesebeck Str. 59-61, 10719, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Haberland+A%22">Haberland A</searchLink>; Berlin Cures GmbH, Dept. Regulatory Affairs, Robert-Rössle-Str. 10, 13125, Berlin, Germany. haberland@berlincures.de.<br /><searchLink fieldCode="AU" term="%22Wenzel+K%22">Wenzel K</searchLink>; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Göttel+P%22">Göttel P</searchLink>; Berlin Cures GmbH, COO, Knesebeck Str. 59-61, 10719, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Wallukat+G%22">Wallukat G</searchLink>; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Davideit+H%22">Davideit H</searchLink>; Berlin Cures GmbH, Dept. Quality Management, Robert-Rössle-Str. 10, 13125, Berlin, Germany.; Life Molecular Imaging GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schulze-Rothe+S%22">Schulze-Rothe S</searchLink>; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hönicke+AS%22">Hönicke AS</searchLink>; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schimke+I%22">Schimke I</searchLink>; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bartel+S%22">Bartel S</searchLink>; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Grossmann+M%22">Grossmann M</searchLink>; Parexel International GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Sinn+A%22">Sinn A</searchLink>; Parexel International GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Iavarone+L%22">Iavarone L</searchLink>; Parexel International GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Boergermann+JH%22">Boergermann JH</searchLink>; Parexel International GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Prilliman+K%22">Prilliman K</searchLink>; Parexel International GmbH, Berlin, Germany.; Veristat, Southborough, MA, United States.<br /><searchLink fieldCode="AU" term="%22Golor+G%22">Golor G</searchLink>; Parexel International GmbH, Berlin, Germany.; Biokinetica GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+J%22">Müller J</searchLink>; Berlin Cures GmbH, CEO, Knesebeck Str. 59-61, 10719, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Becker+S%22">Becker S</searchLink>; Berlin Cures GmbH, Clinical Operations, Knesebeck Str. 59-61, 10719, Berlin, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2020 May; Vol. 40 (5), pp. 433-447.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32222912
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40261-020-00903-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 433
    Titles:
      – TitleFull: A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Becker NP
      – PersonEntity:
          Name:
            NameFull: Haberland A
      – PersonEntity:
          Name:
            NameFull: Wenzel K
      – PersonEntity:
          Name:
            NameFull: Göttel P
      – PersonEntity:
          Name:
            NameFull: Wallukat G
      – PersonEntity:
          Name:
            NameFull: Davideit H
      – PersonEntity:
          Name:
            NameFull: Schulze-Rothe S
      – PersonEntity:
          Name:
            NameFull: Hönicke AS
      – PersonEntity:
          Name:
            NameFull: Schimke I
      – PersonEntity:
          Name:
            NameFull: Bartel S
      – PersonEntity:
          Name:
            NameFull: Grossmann M
      – PersonEntity:
          Name:
            NameFull: Sinn A
      – PersonEntity:
          Name:
            NameFull: Iavarone L
      – PersonEntity:
          Name:
            NameFull: Boergermann JH
      – PersonEntity:
          Name:
            NameFull: Prilliman K
      – PersonEntity:
          Name:
            NameFull: Golor G
      – PersonEntity:
          Name:
            NameFull: Müller J
      – PersonEntity:
          Name:
            NameFull: Becker S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2020 May
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1918
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical drug investigation
              Type: main
ResultId 1